drugset / Trial / NCT00451555
Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to help answer the following research question: whether enzastaurin given together with fulvestrant can help participants who have breast cancer and make the tumor smaller or disappear and for how long.
Timeline
- Start
- 2007-04-11
- Primary completion
- 2010-12-28
- Completion
- 2018-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | enzastaurin | Small molecule | 250 mg | Oral |
| Subject | enzastaurin | Small molecule | 500 mg | Oral |
| Background | Fulvestrant | Small molecule | 250 mg | Intramuscular |